The latest cancer drugs news
Browsing: Cancer Drug News
Blood cancer therapy granted accelerated FDA approval
The US Food and Drug Administration (FDA) has given the green light to Elrexfio™ (elranatamab-bcmm),…
Use of metformin Investigated in prostate cancer treatment
Patients with localised prostate cancer have a good chance of survival, but mortality rates among…
FDA approves melphalan as a liver-directed treatment for uveal melanoma
On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic…
Some costly cancer drugs can have unclear patient benefits
Cancer drugs are a dominant area in the pharmaceutical industry, constantly developing and launching new…
Existing cancer drugs have potential to benefit thousands more patients
New research, published in Nature Genetics, shows that more people may benefit from PARP inhibitor drugs,…
Heart drug improves skin cancer treatment in mice
A collaborative Spanish study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute…
FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions
On August 9, 2023, the Food and Drug Administration granted regular approval to pralsetinib for adult…
FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer
The Food and Drug Administration approved dostarlimab-gxly with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for…
FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer
On August 2, 2023, the Food and Drug Administration approved trifluridine and tipiracil, for metastatic…
Novel bispecific antibodies talquetamab and teclistamab receives positive CHMP opinions for the treatment of relapsed and refractory multiple myeloma
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)…